NCT06023251

Brief Summary

The objective is to increase caloric adequacy in patients who survived critical illness and are admitted to the ward by the use of a pro-active inclusive nutritional strategy including supplemental parenteral and/or enteral nutrition and/or oral nutritional supplements guided by indirect calorimetry. This enables the investigators to address, within a clinical/scientific context, a recently demonstrated but until now relatively neglected 'dark side' of patient care at UZ Brussel, comparable to limited global evidence : iatrogenic malnutrition of ICU survivors. The use of a newly developed clinical pathway and nutrition strategy (oral, enteral and parenteral) led by a single SPoC (Single Point of Contact) for patients surviving intensive care will have a clear objective: to address the nutritional deficit in all patients.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
3mo left

Started Oct 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress89%
Oct 2023Aug 2026

First Submitted

Initial submission to the registry

August 18, 2023

Completed
18 days until next milestone

First Posted

Study publicly available on registry

September 5, 2023

Completed
29 days until next milestone

Study Start

First participant enrolled

October 4, 2023

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2026

Last Updated

March 26, 2024

Status Verified

March 1, 2024

Enrollment Period

2.9 years

First QC Date

August 18, 2023

Last Update Submit

March 22, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Nutrition Adequacy

    Increase of caloric adequacy (from 58 to 80%) and protein adequacy (from 52 to 80%) in ICU survivors

    The adequacy will be calculated over the entire ward stay: from date of inclusion till 28 days later or death from any cause, whichever came first.

Study Arms (1)

Cohort

OTHER

oral food, enteral nutrition, parenteral nutrition

Other: Clinical Nutrition

Interventions

Nutritional care plan implementation, including * A step-up and step-down nutritional protocol guided by caloric and protein ratio * Monitoring plan including daily nutritional intake assessment by a dietician and (para)medical supervision by a nutrition support pharmacist and nurse concerning dysphagia, refeeding syndrome, electrolytes abnormalities and access issues * Indirect calorimetry measurements to assess metabolic needs and body impedance analysis to assess body composition on regular time points * Dedicated and specialized dietician and nurse involvement * Adaptive communication policy (translating to native language) and culturally appropriate food regimens and artificial nutrition.

Cohort

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult ≥ 18 years
  • ICU stay ≥ 7 days
  • Ward stay ≥ 3 days
  • Nutritional therapy not restricted
  • Heterogeneous diseases

You may not qualify if:

  • Patients \< 18 years
  • ICU \< 7 days
  • Ward stay \< 3 days
  • Advanced Care Planning with impact on nutritional therapy
  • Patients with palliative care
  • Metabolic derangements such as metabolic diseases
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UZ Brussel

Brussels, Belgium

RECRUITING

MeSH Terms

Conditions

Malnutrition

Condition Hierarchy (Ancestors)

Nutrition DisordersNutritional and Metabolic Diseases

Study Officials

  • Elisabeth De Waele, MD PhD

    Universitair Ziekenhuis Brussel, Vrije universiteit Brussel

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Zenzi Rosseel, PharmD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Department

Study Record Dates

First Submitted

August 18, 2023

First Posted

September 5, 2023

Study Start

October 4, 2023

Primary Completion (Estimated)

August 31, 2026

Study Completion (Estimated)

August 31, 2026

Last Updated

March 26, 2024

Record last verified: 2024-03

Locations